Motaghinejad et al.36postulated that increased COVID‐19 mortality is partially driven by decreased ACE2 expression in the pulmonary and cardiovascular systems, causing destabilization of Bcl‐2 and dysregulation of apoptosis. This evidence concerns the gene BCL2 and COVID-19.